Hi Semi,
We already worked out last night the only shares that will be issues next week will be the fees payable to the Investor,
Based on the 3b, the cost basis appears to be ~17c.
The funds will be paid next week for Trench 1 and the price will be determined at a later date, by the looks of it, they have up to 2023 to convert the funds into shares and Full funding will not be secured until after the shareholder approval, (2nd Aug)
@Pepper70 - None of my comments have defamed the directors or the company.
Today's announcement had no impact on the SP, which implied to me that many investors didn't understand the deal.
That is why I asked Natos to confirm the deal, Any of the WKT bulls could have posted on HC to explain the 3b to investors prior to me posting (5 hours) yet no one bothered.
The funding is more of a convertible bond or note, rather than a direct equity investment. .As I said last night, the deal appears to be a Win Win for both WKT and the USA Investor.
- Forums
- ASX - By Stock
- WKT
- Ann: Proposed issue of securities - WKT
Ann: Proposed issue of securities - WKT, page-50
Featured News
Add WKT (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $63.76M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WKT (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online